(Q37859361)

24 August 2017

title

Clinical and microbiologic outcomes in trauma patients treated for Stenotrophomonas maltophilia ventilator-associated pneumonia (English)

1 reference

Stenotrophomonas maltophilia

24 August 2017

0 references

1 reference

1 reference

7

Timothy C Fabian

1 reference

24 August 2017

Quinn A Czosnowski

1

1 reference

24 August 2017

G Christopher Wood

2

1 reference

24 August 2017

Louis J Magnotti

3

1 reference

24 August 2017

Martin A Croce

4

1 reference

24 August 2017

Joseph M Swanson

5

1 reference

24 August 2017

Bradley A Boucher

6

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

31

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

338-345

1 reference

Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Infections caused by Stenotrophomonas maltophilia--a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

The effect of late-onset ventilator-associated pneumonia in determining patient mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Differences in early- and late-onset ventilator-associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Duration of antibiotic therapy for ventilator-associated pneumonia caused by non-fermentative gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Efficacy of monotherapy in the treatment of Pseudomonas ventilator-associated pneumonia in patients with trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Empiric antibiotic therapy for suspected ventilator-associated pneumonia: a systematic review and meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Stenotrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: A study of 143 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Multiple-dose pharmacokinetics of 12 milligrams of trimethoprim and 60 milligrams of sulfamethoxazole per kilogram of body weight per day in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

Trimethoprim-sulfamethoxazole induces reversible hyperkalemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.4.338

21 January 2018

Identifiers

DOI

10.1592/PHCO.31.4.338

1 reference

24 August 2017

1 reference